Zhitong Finance App News, Tong Ren Tang (600085.SH) issued an announcement. The company learned that the company's holding company, Beijing Tongrentang Sinopharm Co., Ltd. received a “Proprietary Chinese Medicine Registration Certificate” issued by the Traditional Chinese Medicine Administration Committee of the Hong Kong Special Administrative Region (Hong Kong) of the People's Republic of China (Hong Kong for short), allowing the sale of “Dingzhi Pills [Tong Ren Tang]” in Hong Kong. The main function of this drug is to improve qi, nourish the mind, and calm the mind.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.